Colonization of cecum is important for development of persistent infection by Yersinia pseudotuberculosis

Infection and Immunity

Volumn 82, Issue 8, 2014, Pages 3471-3482

  Fahlgren, Anna ^a   Avican, Kemal ^a   Westermark, Linda ^a   Nordfelth, Roland ^a   Fällman, Maria ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASYMPTOMATIC INFECTION; BACTERIAL COLONIZATION; BACTERIAL SHEDDING; BACTERIAL VIRULENCE; BIOLUMINESCENCE; CECUM; CONTROLLED STUDY; FECES; FEMALE; INFLAMMATION; MOUSE; NONHUMAN; PATHOGENESIS; PERSISTENT INFECTION; PRIORITY JOURNAL; YERSINIA PSEUDOTUBERCULOSIS; YERSINIA PSEUDOTUBERCULOSIS INFECTION;

ANIMALS; BACTERIAL SHEDDING; CECUM; DISEASE MODELS, ANIMAL; FECES; FEMALE; LUMINESCENT MEASUREMENTS; MICE; WHOLE BODY IMAGING; YERSINIA PSEUDOTUBERCULOSIS; YERSINIA PSEUDOTUBERCULOSIS INFECTIONS;

EID: 84904727626     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01793-14     Document Type: Article

References (46)

1. Rhen M, Eriksson S, Clements M, Bergstrom S, Normark SJ. 2003. The basis of persistent bacterial infections. Trends Microbiol. 11:80-86. http: //dx.doi.org/10.1016/S0966-842X(02)00038-0.
2. Monack DM, Mueller A, Falkow S. 2004. Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat. Rev. Microbiol. 2:747-765. http://dx.doi.org/10.1038/nrmicro955.
3. Grant SS, Hung DT. 2013. Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response. Virulence 4:273-283. http://dx .doi.org/10.4161/viru.23987.
4. Marteau P, Chaput U. 2011. Bacteria as trigger for chronic gastrointestinal disorders. Dig. Dis. 29:166 -171. http://dx.doi.org/10.1159 /000323879.
5. Galindo CL, Rosenzweig JA, Kirtley ML, Chopra AK. 2011. Pathogenesis of Y. enterocolitica and Y. pseudotuberculosis in human yersiniosis. J. Pathog. 2011:182051. http://dx.doi.org/10.4061/2011/182051.
6. Zganjer M, Roic G, Cizmic A, Pajic A. 2005. Infectious ileocecitis- appendicitis mimicking syndrome. Bratisl. Lek. Listy 106:201-202.
7. Hanski C, Kutschka U, Schmoranzer HP, Naumann M, Stallmach A, Hahn H, Menge H, Riecken EO. 1989. Immunohistochemical and electron microscopic study of interaction of Yersinia enterocolitica serotype O8 with intestinal mucosa during experimental enteritis. Infect. Immun. 57:673-678.
8. Marra A, Isberg RR. 1997. Invasin-dependent and invasin-independent pathways for translocation of Yersinia pseudotuberculosis across the Peyer's patch intestinal epithelium. Infect. Immun. 65:3412-3421.
9. Clark MA, Hirst BH, Jepson MA. 1998. M-cell surface beta1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells. Infect. Immun. 66:1237-1243.
10. Barnes PD, Bergman MA, Mecsas J, Isberg RR. 2006. Yersinia pseudotuberculosis disseminates directly from a replicating bacterial pool in the intestine. J. Exp. Med. 203:1591-1601. http://dx.doi.org/10.1084/jem .20060905.
11. Galan JE, Wolf-Watz H. 2006. Protein delivery into eukaryotic cells by type III secretion machines. Nature 444:567-573. http://dx.doi.org/10 .1038/nature05272.
12. Durand EA, Maldonado-Arocho FJ, Castillo C, Walsh RL, Mecsas J. 2010. The presence of professional phagocytes dictates the number of host cells targeted for Yop translocation during infection. Cell. Microbiol. 12: 1064-1082. http://dx.doi.org/10.1111/j.1462-5822.2010.01451.x.
13. Cornelis GR. 2002. The Yersinia Ysc-Yop 'type III' weaponry. Nat. Rev. Mol. Cell Biol. 3:742-752. http://dx.doi.org/10.1038/nrm932.
14. Heesemann J, Sing A, Trulzsch K. 2006. Yersinia's stratagem: targeting innate and adaptive immune defense. Curr. Opin. Microbiol. 9:55-61. http://dx.doi.org/10.1016/j.mib.2005.10.018.
15. Viboud GI, Bliska JB. 2005. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu. Rev. Microbiol. 59: 69-89. http://dx.doi.org/10.1146/annurev.micro.59.030804.121320.
16. Girschick HJ, Guilherme L, Inman RD, Latsch K, Rihl M, Sherer Y, Shoenfeld Y, Zeidler H, Arienti S, Doria A. 2008. Bacterial triggers and autoimmune rheumatic diseases. Clin. Exp. Rheumatol. 26:S12-S17.
17. Hoogkamp-Korstanje JA, de Koning J, Heesemann J. 1988. Persistence of Yersinia enterocolitica in man. Infection 16:81-85. http://dx.doi.org/10 .1007/BF01644307.
18. de Koning J, Heesemann J, Hoogkamp-Korstanje JA, Festen JJ, Houtman PM, van Oijen PL. 1989. Yersinia in intestinal biopsy specimens from patients with seronegative spondyloarthropathy: correlation with specific serum IgA antibodies. J. Infect. Dis. 159:109-112. http://dx.doi .org/10.1093/infdis/159.1.109.
19. Ternhag A, Torner A, Svensson A, Ekdahl K, Giesecke J. 2008. Shortand long-term effects of bacterial gastrointestinal infections. Emerg. Infect. Dis. 14:143-148. http://dx.doi.org/10.3201/eid1401.070524.
20. Westermark L, Fahlgren A, Fallman M. 30 December 2013. Yersinia pseudotuberculosis efficiently escapes polymorphonuclear neutrophils during early infection. Infect. Immun. http://dx.doi.org/10.1128/IAI .01634-13.
21. Isaksson EL, Aili M, Fahlgren A, Carlsson SE, Rosqvist R, Wolf-Watz H. 2009. The membrane localization domain is required for intracellular localization and autoregulation of YopE in Yersinia pseudotuberculosis. Infect. Immun. 77:4740-4749. http://dx.doi.org/10.1128/IAI.00333-09.
22. Piwnica-Worms D, Schuster DP, Garbow JR. 2004. Molecular imaging of host-pathogen interactions in intact small animals. Cell. Microbiol. 6:319-331. http://dx.doi.org/10.1111/j.1462-5822.2004.00379.x.
23. Mecsas J, Bilis I, Falkow S. 2001. Identification of attenuated Yersinia pseudotuberculosis strains and characterization of an orogastric infection in BALB/c mice on day 5 postinfection by signature-tagged mutagenesis. Infect. Immun. 69:2779-2787. http://dx.doi.org/10.1128/IAI.67.5.2779 -2787.2001.
24. Logsdon LK, Mecsas J. 2003. Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues. Infect. Immun. 71:4595-4607. http://dx.doi.org /10.1128/IAI.71.8.4595-4607.2003.
25. Monack DM, Mecsas J, Ghori N, Falkow S. 1997. Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc. Natl. Acad. Sci. U. S. A. 94:10385-10390. http://dx.doi.org/10 .1073/pnas.94.19.10385.
26. Meinzer U, Barreau F, Esmiol-Welterlin S, Jung C, Villard C, Leger T, Ben-Mkaddem S, Berrebi D, Dussaillant M, Alnabhani Z, Roy M, Bonacorsi S, Wolf-Watz H, Perroy J, Ollendorff V, Hugot JP. 2012. Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction. Cell Host Microbe 11:337-351. http://dx.doi.org/10.1016/j.chom.2012.02 .009.
27. Carter PB. 1975. Animal model of human disease. Yersinia enteritis. Animal model: oral Yersinia enterocolitica infection of mice. Am. J. Pathol. 81:703-706.
28. Yeruva L, Spencer N, Bowlin AK, Wang Y, Rank RG. 2013. Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection. Pathog. Dis. 68:88-95. http://dx.doi.org/10.1111/2049-632X.12052.
29. Hancock GE, Schaedler RW, MacDonald TT. 1986. Yersinia enterocolitica infection in resistant and susceptible strains of mice. Infect. Immun. 53:26-31.
30. Autenrieth IB, Beer M, Bohn E, Kaufmann SH, Heesemann J. 1994. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect. Immun. 62:2590-2599.
31. Schippers A, Mateika S, Prochnow B, Gruber AD, Muller W, Frischmann U. 2008. Susceptibility of four inbred mouse strains to a low-pathogenic isolate of Yersinia enterocolitica. Mamm. Genome 19: 279-291. http://dx.doi.org/10.1007/s00335-008-9105-1.
32. Meinzer U, Esmiol-Welterlin S, Barreau F, Berrebi D, Dussaillant M, Bonacorsi S, Chareyre F, Niwa-Kawakita M, Alberti C, Sterkers G, Villard C, Lesuffleur T, Peuchmaur M, Karin M, Eckmann L, Giovannini M, Ollendorff V, Wolf-Watz H, Hugot JP. 2008. Nod2 mediates susceptibility to Yersinia pseudotuberculosis in mice. PLoS One 3:e2769. http://dx.doi.org/10.1371/journal.pone.0002769.
33. Kadioglu A, Andrew PW. 2005. Susceptibility and resistance to pneumococcal disease in mice. Brief. Funct. Genomic. Proteomic. 4:241-247. http: //dx.doi.org/10.1093/bfgp/4.3.241.
34. Azoulay-Cayla A, Syan S, Brahic M, Bureau JF. 2001. Roles of the H-2D(b) and H-K(b) genes in resistance to persistent Theiler's murine encephalomyelitis virus infection of the central nervous system. J. Gen. Virol. 82:1043-1047.
35. Andersson K, Magnusson KE, Majeed M, Stendahl O, Fallman M. 1999. Yersinia pseudotuberculosis-induced calcium signaling in neutrophils is blocked by the virulence effector YopH. Infect. Immun. 67:2567-2574.
36. Fahlgren A, Westermark L, Akopyan K, Fallman M. 2009. Cell typespecific effects of Yersinia pseudotuberculosis virulence effectors. Cell. Microbiol. 11:1750-1767. http://dx.doi.org/10.1111/j.1462-5822.2009 .01365.x.
37. Wang X, Gu W, Qiu H, Xia S, Zheng H, Xiao Y, Liang J, Jing H. 2013. Comparison of the cytokine immune response to pathogenic Yersinia enterocolitica bioserotype 1B/O:8 and 2/O:9 in susceptible BALB/C and resistant C57BL/6 mice. Mol. Immunol. 55:365-371. http://dx.doi.org/10 .1016/j.molimm.2013.03.017.
38. Toivanen A, Toivanen P. 2000. Reactive arthritis. Curr. Opin. Rheumatol. 12:300-305. http://dx.doi.org/10.1097/00002281-200007000-00012.
39. Mair NS, Fox E, Thal E. 1979. Biochemical, pathogenicity and toxicity studies of type III strains of Yersinia pseudotuberculosis isolated from the cecal contents of pigs. Contrib. Microbiol. Immunol. 5:359-365.
40. Fredriksson-Ahomaa M, Stolle A, Siitonen A, Korkeala H. 2006. Sporadic human Yersinia enterocolitica infections caused by bioserotype 4/O:3 originate mainly from pigs. J. Med. Microbiol. 55:747-749. http: //dx.doi.org/10.1099/jmm.0.46523-0.
41. Bonardi S, Paris A, Bassi L, Salmi F, Bacci C, Riboldi E, Boni E, D'Incau M, Tagliabue S, Brindani F. 2010. Detection, semiquantitative enumeration, and antimicrobial susceptibility of Yersinia enterocolitica in pork and chicken meats in Italy. J. Food Prot. 73:1785-1792.
42. Backhans A, Fellstrom C, Lambertz ST. 2011. Occurrence of pathogenic Yersinia enterocolitica and Yersinia pseudotuberculosis in small wild rodents. Epidemiol. Infect. 139:1230 -1238. http://dx.doi.org/10.1017 /S0950268810002463.
43. Puylaert JB, Van der Zant FM, Mutsaers JA. 1997. Infectious ileocecitis caused by Yersinia, Campylobacter, and Salmonella: clinical, radiological and US findings. Eur. Radiol. 7:3-9. http://dx.doi.org/10 .1007/s003300050098.
44. Watson GT, Huaman MA, Semler MW, Manners J, Woron AM, Carpenter LR, Christman BW. 2013. When nature meets nurture: persistent Yersinia infection. Am. J. Med. 126:578-580. http://dx.doi.org/10.1016/j .amjmed.2013.03.006.
45. Netea MG, van der Leij F, Drenth JP, Joosten LA, te Morsche R, Verweij P, de Jong D, Kullberg BJ, van der Meer JW. 2010. Chronic yersiniosis due to defects in the TLR5 andNOD2recognition pathways. Neth. J. Med. 68:310-315.
46. Hannu T, Mattila L, Nuorti JP, Ruutu P, Mikkola J, Siitonen A, Leirisalo-Repo M. 2003. Reactive arthritis after an outbreak of Yersinia pseudotuberculosis serotype O:3 infection. Ann. Rheum. Dis. 62:866- 869. http://dx.doi.org/10.1136/ard.62.9.866.